Discovery of AMG 900, a highly selective, orally bioavailable inhibitor of Aurora kinases with efficacy in preclinical antitumor models and activity against multidrug-resistant cancer cell lines

Stephanie Geuns-meyer

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com